New brain device offers hope for autism symptoms in children
Disease control
Not yet recruiting
This study is testing whether a noninvasive brain stimulation device can safely improve core symptoms of autism in children. Researchers will enroll 256 children aged 3-12 with mild to moderate autism who use some spoken language. Half will receive real treatment sessions and hal…
Phase: NA • Sponsor: Neurocytonix, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC